Fbdd-Lit (auto-discovered)

Peter Kenny responded to Pat Walters' critique of the OpenADMET initiative, defending the role of machine learning in modern drug discovery. Kenny argued that Walters mischaracterized the utility of M…

A developer reviews a study on comparing machine learning models in small molecule drug discovery, arguing that the credibility of the field would improve if journals banned the word 'outperform'. The…